Sarepta Therapeutics (SRPT) Gains from Investment Securities (2012 - 2014)

Sarepta Therapeutics' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$4.3 million for Q3 2014.

• In Q3 2014, Gains from Investment Securities fell 124.8% year-over-year to -$4.3 million; the TTM figure through Dec 2014 stood at $2.8 million (down 87.38% YoY), while the FY2014 annual figure was $2.8 million, down 87.38% from the prior year.
• Gains from Investment Securities for Q3 2014 stood at -$4.3 million, down from $3.8 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $51.8 million in Q4 2012, with the low at -$24.0 million in Q4 2013.
• The 3-year median for Gains from Investment Securities is $3.8 million (2014), against an average of $10.6 million.
• Peak annual rise in Gains from Investment Securities reached 146.26% in 2013, while the deepest fall reached 146.32% in 2013.
• Sarepta Therapeutics' Gains from Investment Securities stood at $51.8 million in 2012, then plunged by 146.32% to -$24.0 million in 2013, then soared by 82.25% to -$4.3 million in 2014.
• Business Quant data shows SRPT's Gains from Investment Securities at -$4.3 million in Q3 2014, $3.8 million in Q2 2014, and $3.3 million in Q1 2014.